STOCK TITAN

[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity

BIO-RAD LABORATORIES, INC.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BIO-RAD LABORATORIES, INC. (symbol: BIO) is the issuer of record for a Form 4 filing submitted to the SEC.

Positive

  • None.

Negative

  • None.
Insider SCHWARTZ NORMAN D
Role Chairman & CEO
Type Security Shares Price Value
Exercise Restricted Stock Units F5, F6 2,082 $0.00 $0.00
Exercise Restricted Stock Units F5, F7 3,005 $0.00 $0.00
Exercise Bio-Rad A Common Stock F1 5,087 $0.00 $0.00
Exercise Price or Tax Liability Bio-Rad A Common Stock 2,336 $380.96 $890K
holding Bio-Rad B Common Stock -- -- --
holding Bio-Rad B Common Stock F2 -- -- --
holding Bio-Rad B Common Stock F3 -- -- --
holding Bio-Rad A Common Stock F4 -- -- --
holding Bio-Rad A Common Stock F4 -- -- --
holding Bio-Rad A Common Stock F4 -- -- --
holding Bio-Rad A Common Stock F4 -- -- --
holding Bio-Rad B Common Stock F4 -- -- --
holding Bio-Rad A Common Stock F4 -- -- --
holding Bio-Rad B Common Stock F4 -- -- --
Holdings After Transaction: Restricted Stock Units — 3,005 contracts (Direct); Bio-Rad A Common Stock — 446,185 shares (Direct); Bio-Rad B Common Stock — 361,466 shares (Direct); Bio-Rad B Common Stock — 13,006 shares (Indirect, By Spouse); Bio-Rad B Common Stock — 4,060,054 shares (Indirect, By Blue Raven Partners, L.P.); Bio-Rad A Common Stock — 1,781,356 shares (Indirect, By Alice N. Schwartz Revocable Trust); Bio-Rad A Common Stock — 90 shares (Indirect, By David Schwartz Exemption Trust); Bio-Rad A Common Stock — 240 shares (Indirect, By David Schwartz Exempt Martial Trust); Bio-Rad A Common Stock — 898,931 shares (Indirect, By David Schwartz Non-Exempt Martial Trust); Bio-Rad B Common Stock — 57,000 shares (Indirect, By David Schwartz Non-Exempt Martial Trust); Bio-Rad A Common Stock — 34,311 shares (Indirect, By Charitable Remainder Unitrust); Bio-Rad B Common Stock — 437,510 shares (Indirect, By Alice N. Schwartz Revocable Trust)
Footnotes (7)
  1. F1. Shares of Class A common stock acquired on the vesting of restricted stock units.
  2. F2. The reporting person disclaims beneficial ownership of these shares.
  3. F3. The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  4. F4. The shares are held by in trust of which the reporting person serves as the trustee. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  5. F5. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
  6. F6. On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  7. F7. On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SCHWARTZ NORMAN D

(Last)(First)(Middle)
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE

(Street)
HERCULES CALIFORNIA 94547

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BIO-RAD LABORATORIES, INC. [ BIO BIO.B ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chairman & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Bio-Rad A Common Stock09/01/2026M5,087(1)A$0448,521D
Bio-Rad A Common Stock09/01/2026F2,336D$380.96446,185D
Bio-Rad B Common Stock361,466D
Bio-Rad B Common Stock13,006IBy Spouse(2)
Bio-Rad B Common Stock4,060,054IBy Blue Raven Partners, L.P.(3)
Bio-Rad A Common Stock1,781,356IBy Alice N. Schwartz Revocable Trust(4)
Bio-Rad A Common Stock90IBy David Schwartz Exemption Trust(4)
Bio-Rad A Common Stock240IBy David Schwartz Exempt Martial Trust(4)
Bio-Rad A Common Stock898,931IBy David Schwartz Non-Exempt Martial Trust(4)
Bio-Rad B Common Stock57,000IBy David Schwartz Non-Exempt Martial Trust(4)
Bio-Rad A Common Stock34,311IBy Charitable Remainder Unitrust(4)
Bio-Rad B Common Stock437,510IBy Alice N. Schwartz Revocable Trust(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$0(5)09/01/2026M2,082 (6) (6)Bio-Rad A Common Stock2,082$00D
Restricted Stock Units$0(5)09/01/2026M3,005 (7) (7)Bio-Rad A Common Stock3,005$03,005D
Explanation of Responses:
1. Shares of Class A common stock acquired on the vesting of restricted stock units.
2. The reporting person disclaims beneficial ownership of these shares.
3. The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
4. The shares are held by in trust of which the reporting person serves as the trustee. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
5. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
6. On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
7. On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Remarks:
/s/ Norman Schwartz09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)